Results 241 to 250 of about 119,313 (287)
Development of a multi-analyte acoustic biosensing platform for clinical diagnostics
Κωνσταντίνος Μητσακάκης
openalex +2 more sources
We present a dual‐organ, biomarker‐integrated ovaryendometrium organ‐on‐a‐chip that recapitulates 3D tissue complexity, menstrual cycle dynamics, and hormonal crosstalk. This platform enables real‐time, cell‐typespecific fluorescent readouts of reproductive toxicity using ANGPTL4 and SERPINB2 as early‐response reporters.
Soo‐Rim Kim +6 more
wiley +1 more source
Integrating Polymeric 3D-Printed Microneedles with Wearable Devices: Toward Smart and Personalized Healthcare Solutions. [PDF]
Razzaghi M.
europepmc +1 more source
Electrochemiluminescence Drives Photodynamic Therapy In Vivo
Electrochemiluminescence (ECL)‐driven photodynamic therapy (PDT) for in vivo cancer treatment is reported for the first time. The flexible ECL patch exhibits stable and intense luminance under alternating current voltage, enabling efficient photosensitization to generate reactive oxygen species that damage cancer cells, thus leading to significant ...
Jia‐Bao Lin +5 more
wiley +1 more source
Recent advances and future prospects of metal organic frameworks (MOF)-based biosensors. [PDF]
Karimzadeh Z.
europepmc +1 more source
In this work, we showcased two significant scientific advances in (i) developing a portable biosensor technology for rapid decentralized prostate cancer urinary biomarker testing and reporting, with superior performance to current clinical testing practice; and (ii) proposing a clinical validation framework (for our biosensor development) which can be ...
Kevin M. Koo +14 more
wiley +1 more source
Deep Learning-Enhanced Nanozyme-Based Biosensors for Next-Generation Medical Diagnostics. [PDF]
Lee S, Moussa NAM, Kang SH.
europepmc +1 more source
Analysis of noise in differential and ratiometric biosensing systems
Sidahmed Abayzeed +3 more
openalex +1 more source
We designed a synthetic DNA origami needle‐like structure inspired by bacteriophages for targeted drug delivery. Functionalized with trastuzumab antibodies, cholesterol, and dyes, it selectively targets SKBR3 cancer cells. A glutathione‐triggered dye payload enables controlled release, and delivery is verified using confocal microscopy and live cell ...
Anirban Samanta +7 more
wiley +1 more source

